Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000019617-17-000083
Filing Date
2017-01-13
Accepted
2017-01-13 13:19:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 AXSOME_THERAPEUTICS_INC.HTM SC 13G/A 41275
  Complete submission text file 0000019617-17-000083.txt   43082
Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVE 38TH FL NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Subject) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89198 | Film No.: 17527259
SIC: 2834 Pharmaceutical Preparations